Coagulation and renal disease.
D058186:Acute Kidney Injury / Q000209:etiology; D000804:Angiotensin II / Q000009:adverse effects; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000150:complications* / Q000276:immunology; D002395:Catecholamines / Q000009:adverse effects; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D005260:Female; D005337:Fibrin / Q000009:adverse effects; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006977:Hypertension, Renal / Q000209:etiology; D007674:Kidney Diseases / Q000150:complications / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D007678:Kidney Glomerulus / Q000276:immunology / Q000473:pathology; D011225:Pre-Eclampsia / Q000150:complications / Q000473:pathology; D011247:Pregnancy; D012083:Renin / Q000009:adverse effects; D013927:Thrombosis / Q000150:complications / Q000209:etiology; D014511:Uremia / Q000473:pathology
D000925:Anticoagulants; D002395:Catecholamines; D000804:Angiotensin II; D005337:Fibrin; D006493:Heparin; D012083:Renin